Treatment of Asthma: Budemet inhaler is indicated for the treatment of asthma in patients 12 years of age and older. This is not indicated for the relief of acute bronchospasm.
Maintenance treatment of Chronic Obstructive Pulmonary Disease (COPD): Budemet inhalation capsule is indicated for the twice-daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema. This inhalation capsule is the only approved dosage for the treatment of airflow obstruction in COPD.
Maintenance treatment of Chronic Obstructive Pulmonary Disease (COPD): Budemet inhalation capsule is indicated for the twice-daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema. This inhalation capsule is the only approved dosage for the treatment of airflow obstruction in COPD.